Phase I study of erlotinib (tarceva) and temsirolimus (CCI-779) for patients with recurrent malignant gliomas (NABTC 04-02)

被引：0
|
作者：
Wen, P. Y.
Chang, S. M.
Kuhn, J.
Lamborn, K.
Robins, H. I.
Cloughesy, T.
Gilbert, M. R.
Yung, W. K. A.
Mehta, M.
DeAngelis, L. M.
Abrey, L. E.
Kesari, S.
Drappatz, J.
Lassman, A. B.
Dancey, J.
Prados, M. D.
机构：
[1] N Amer Brain Tumor Consortium, Bethesda, MD USA
[2] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA
来源：
NEURO-ONCOLOGY | 2006年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：454 / 454
页数：1
相关论文
共 50 条
  • [31] Phase I pharmacokinetic study of temsirolimus (CCI-779) in patients with advanced malignancies and normal and impaired liver function: An NCI Organ Dysfunction Working Group (ODWG) study.
    Sarantopoulos, J.
    Lenz, H.
    LoRusso, P.
    Shibata, S.
    Kummar, S.
    Mulkerin, D.
    Ramanathan, R. K.
    Mita, M. M.
    O'Rourke, P.
    Remick, S. C.
    Goel, S.
    Gutierrez, M.
    Ramalingam, S. S.
    Murgo, A.
    Davies, A. M.
    Mani, S.
    Boni, J.
    Shapiro, M.
    Ivy, S. P.
    Takimoto, C. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] A phase I and pharmacological study of CCI-779, a rapamycin ester cell cycle inhibitor.
    Hidalgo, M
    Rowinsky, E
    Erlichman, C
    Drengler, R
    Marshall, B
    Marks, R
    Edwards, T
    Boni, J
    Dukart, G
    Buckner, J
    ANNALS OF ONCOLOGY, 2000, 11 : 133 - 133
  • [33] Phase I study of vorinostat (suberoylanilide hydroxamic acid) in combination with temozolomide (TMZ) in patients with malignant gliomas (NABTC 04-03)
    Wen, P. Y.
    Puduvalli, V.
    Kuhn, J.
    Reid, J.
    Cloughesy, T.
    Yung, W. A.
    Chang, S. M.
    Robbins, H. I.
    McGovern, R.
    Ames, M.
    Prados, M. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Phase I study of vorinostat (suberoylanilide hydroxamic acid [SAHA]) in combination with temozolomide in patients with malignant gliomas (NABTC 04-03)
    Wen, Patrick
    Puduvalli, Vinay
    Kuhn, John
    Reid, Joel
    Cloughesy, Timothy
    Yung, Wka
    Drappatz, Jan
    Lamborn, Kathleen
    Gilbert, Mark
    Butowski, Nicholas
    Levin, Victor
    Chang, Susan
    Kesari, Santosh
    Robbins, Hi
    McGovern, Renee
    Richon, Victoria
    Frankel, Stanley
    Ames, Matthew
    Zweibel, James
    Prados, Michael
    NEURO-ONCOLOGY, 2007, 9 (04) : 518 - 518
  • [35] NCCTG phase I trial of temsirolimus (CCI-779) and temozolomide (TMZ) in combination with radiation therapy (RT) in newly diagnosed glioblastoma multiforme (GBM) patients
    Sarkaria, J. N.
    Galanis, E.
    Wu, W.
    Giannini, C.
    Jaeckle, K. A.
    Doyle, L.
    Uhm, J.
    Brown, P.
    Dietz, A. B.
    Buckner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] A PHASE 2 STUDY OF SAFETY AND EFFICACY OF TEMSIROLIMUS (CCI-779) ADMINISTERED AS A SINGLE AGENT IN EAST ASIAN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA
    Sun, Y.
    Rha, S. Y.
    Lee, S.
    Guo, J.
    Ueda, T.
    Qin, S.
    Naito, S.
    Cincotta, M.
    Tokushige, K.
    Akaza, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 290 - 290
  • [37] DASATINIB (SPRYCEL) AND ERLOTINIB (TARCEVA) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE 1 TRIAL
    Desjardins, Annick
    Peters, Katherine B.
    Vredenburgh, James J.
    Friedman, Henry S.
    Reardon, David A.
    NEURO-ONCOLOGY, 2010, 12 : 51 - 51
  • [38] FEASIBILITY/TOLERABILITY RESULTS FROM A PHASE I/II STUDY OF TEMSIROLIMUS (CCI-779) AND SORAFENIB IN RECURRENT GLIOBLASTOMA: NORTH CENTRAL CANCER TREATMENT GROUP (NCCTG) N0572
    Schiff, David
    Sarkaria, Jann
    Decker, Paul
    Buckner, Jan
    Galanis, Evanthia
    Dancey, Janet
    Giannini, Caterina
    Brown, Paul
    Wiesenfeld, Martin
    Jaeckle, Kurt
    NEURO-ONCOLOGY, 2009, 11 (02) : 232 - 232
  • [39] Phase I study of intravenous CCI-779 in combination with bryostatin-1 in solid tumors.
    Haas, N. B.
    Lewis, N.
    Cohen, R. B.
    Malizzia, L.
    Einarson, M. B.
    Walker, M. A.
    Kim, T.
    Von Mehren, M.
    Hudes, G. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 137S - 137S
  • [40] Phase I Trial of Lenalidomide and CCI-779 in Patients With Relapsed Multiple Myeloma: Evidence for Lenalidomide-CCI-779 Interaction via P-Glycoprotein
    Hofmeister, Craig C.
    Yang, Xiaoxia
    Pichiorri, Flavia
    Chen, Ping
    Rozewski, Darlene M.
    Johnson, Amy J.
    Lee, Seungsoo
    Liu, Zhongfa
    Garr, Celia L.
    Hade, Erinn M.
    Ji, Jia
    Schaaf, Larry J.
    Benson, Don M., Jr.
    Kraut, Eric H.
    Hicks, William J.
    Chan, Kenneth K.
    Chen, Ching-Shih
    Farag, Sherif S.
    Grever, Michael R.
    Byrd, John C.
    Phelps, Mitch A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (25) : 3427 - 3434
12345